CASODEX - PRECLINICAL STUDIES AND CONTROVERSIES

被引:10
作者
FURR, BJA
机构
[1] Department Zeneca Pharmaceuticals, Macclesfield, Cheshire, SK10 4TG, Alderley Park
来源
STEROID RECEPTORS AND ANTIHORMONES | 1995年 / 761卷
关键词
D O I
10.1111/j.1749-6632.1995.tb31371.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:79 / 96
页数:18
相关论文
共 53 条
[51]  
Migliari R., Muscas G., Usai E., Effect of ‘Casodex’ on sleep‐related erections in patients with advanced prostate cancer, J. Urol., 148, pp. 338-341, (1992)
[52]  
Eri L.M., Tveter K.J., Safety, side‐effects and patient acceptability of the antiandrogen ‘Casodex’ in the treatment of benign prostatic hypertrophy, Eur. Urol., 26, pp. 219-226, (1994)
[53]  
Verhelst J., Denis L., Van Vliet P., Van Poppel H., Braeckman J., Van Cangh P., Mattelaer D., D'Hulster D., Mahler Ch., Endocrine profiles during administration of the new non‐steroidal anti‐androgen ‘Casodex’ in prostate cancer, Clin. Endocrinol., 41, pp. 525-530, (1994)